Journey Advisory Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Journey Advisory Group's MDT Position: Q2 2026 in Review
Journey Advisory Group increased its Medtronic (MDT) stake by 2,312% in Q2 2026, buying an estimated $4.8M and bringing the position to 62,121 shares worth $4.9M. The position accounts for 0.37% of the portfolio, ranked #78.
Journey Advisory Group first reported a position in MDT in Q4 2020 and has held it in 22 quarters since. 1,527 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Journey Advisory Group held 62,121 shares of Medtronic worth $4.9M as of Q2 2026.
- Journey Advisory Group bought 59,546 Medtronic shares in Q2 2026, an estimated $4.8M.
- Medtronic made up 0.37% of Journey Advisory Group's portfolio in Q2 2026, its #78 holding.
- Journey Advisory Group first reported a position in Medtronic in Q4 2020 and has held it in 22 quarters since.
- 1,527 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.